Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Apo2L/TRAIL

  • You have access
    Nitric Oxide Inhibits NF-κB-mediated Survival Signaling: Possible Role in Overcoming TRAIL Resistance
    JOSEPH A. BAUER, JOSEPH A. LUPICA, JOSEPH A. DIDONATO and DANIEL J. LINDNER
    Anticancer Research December 2020, 40 (12) 6751-6763; DOI: https://doi.org/10.21873/anticanres.14698
  • You have access
    Doxorubicin Overcomes Resistance to Drozitumab by Antagonizing Inhibitor of Apoptosis Proteins (IAPs)
    IRENE ZINONOS, AGATHA LABRINIDIS, VASILIOS LIAPIS, SHELLEY HAY, VASILIOS PANAGOPOULOS, MARK DENICHILO, VLADIMIR PONOMAREV, WENDY INGMAN, GERALD J. ATKINS, DAVID M. FINDLAY, ANDREW C.W. ZANNETTINO and ANDREAS EVDOKIOU
    Anticancer Research December 2014, 34 (12) 7007-7020;
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire